ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD

by Corey, K.E, Finkel, N., Gee, D.W, Gerszten, R.E, Gustafson, J.L, Hutter, M.M, Jacob, J., Jennings, L.L, Lai, M., Loureiro, J., Masia, R., Meireles, O.R, Ngo, D., Osganian, S.A, Pitts, R., Richards, S.M, Ukomadu, C., Wang, T.J, Witkowski, E.R
Published 2022

Distinct Hepatic Gene-Expression Patterns of NAFLD in Patients With Obesity

by Bartsch, L.M, Bhatia, S.N, Bredella, M.A, Chung, R.T, Corey, K.E, Dichtel, L.E, Drescher, H.K, Gee, D.W, Gelrud, L., Gustafson, J.L, Hutter, M.M, Lauer, G.M, Masia, R., Meireles, O.R, Miller, K.K, Osganian, S.A, Rwema, S., Subudhi, S., Warren, A., Witkowski, E.R
Published 2022